Cargando…
INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
Background: Insulinoma-associated protein 1 (INSM1) has been considered as a novel immunostain for neuroendocrine tumors (NETs) and is hypothesized to be more reliable than first-generation NET biomarkers, such as CGA (chromogranin A), SYP (synaptophysin) and CD56 (neural cell adhesion molecule). In...
Autores principales: | Maleki, Zahra, Nadella, Akash, Nadella, Mohnish, Patel, Gopi, Patel, Shivni, Kholová, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700458/ https://www.ncbi.nlm.nih.gov/pubmed/34943408 http://dx.doi.org/10.3390/diagnostics11122172 |
Ejemplares similares
-
Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix
por: Kuji, Shiho, et al.
Publicado: (2022) -
INSM1 Expression in Breast Neoplasms with Neuroedocrine Features
por: Metovic, Jasna, et al.
Publicado: (2021) -
Oncocytic lesion of parotid gland: A dilemma for cytopathologists
por: Chakrabarti, Indranil, et al.
Publicado: (2012) -
Ossifying fibromyxoid tumor — Diagnostic challenge for a cytopathologist
por: Goyal, Prashant, et al.
Publicado: (2012) -
Giant Pilomatricoma of the arm: A diagnostic challenge for cytopathologist
por: Khandeparkar, Siddhi Gaurish Sinai, et al.
Publicado: (2016)